The OSUCCC – James presses on during COVID-19 with its continued commitment to research and patient care
If there's one thing that has come to fruition over the last nine months, it’s that we're all stronger than we think. Cancer doesn't slow down–not even when the world does. Throughout the COVID-19 global pandemic, we've been pushed to our limits and tested beyond belief. Even amidst this adversity, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute never lost sight of its mission: to create a cancer-free world.
Sameek Roychowdhury, MD, PhD and his Precision Cancer Medicine research team have been a testament of resilience during this challenging time. They have refused to let a global pandemic disrupt the critical research conducted every single day at the OSUCCC – James. Dr. Roychowdhury’s team adapted by continuing their work remotely, wherever that may be. They have proven to be more dedicated than ever to their research, and are a reminder to us all to persevere no matter the uncertainty.
Thank you for supporting our research
